Shopping Cart

No products in the cart.


Join the SCWD 2023 Conference in Stockholm to connect with experts, showcase your solutions, and support educational and networking opportunities in cachexia and sarcopenia research and care.

Dear Colleague

The 16th international Conference of the Society on Cachexia, Sarcopenia & Muscle Wasting, will take place on 17-19 June 2023 in Stockholm, Sweden, under the guidance of Chairs of the SCWD, Professor Stefan Anker (Berlin, Germany) and Professor Gianluigi Savarese (Stockholm, Sweden).

It is clear that cachexia and sarcopenia represent an ever-increasing burden for health-care systems, patients and healthcare professionals.

To make sure the international community around the world keeps abreast with the latest advancements after the challenging COVID 19 pandemic and the recent events in Eastern Europe, the Board of the SCWD is determined to create the best possible conditions for the cachexia and sarcopenia community to meet in person.

SCWD will also make sure highlights of the conference are accessible with virtual options to attend remotely via our digital interactive platform.

Our program in 2023 will be take place over 3 days, with basic science and clinical tracks. Poster sessions will be held on site in Stockholm in order to renew with the productive scientific exchange that characterizes academic spirit. Industry sessions will offer the opportunity to share the latest up-to-date research and to discuss and debate best strategies to meet patient needs.

There will also be opportunities to enhance visibility for your solutions during the conference such as exhibition spaces.

By supporting an educational or networking session and exhibiting at the meeting, your organization can develop relationships with the professionals at the head of research and care.

Please take some time to carefully examine the 2023 prospectus and discover how you can become involved in supporting this increasingly important and influential educational initiative.

We hope to see you in Stockholm and look forward to working with you again to continue the tradition of a mutually rewarding and intellectually stimulating SCWD conference!


For more information on sponsorship opportunities please contact

Our Valued Sponsors 2023

Supporting SCWD's Mission to Advance Medical Research





Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!

Helsinn is a fully integrated global biopharma company headquartered in Lugano, Switzerland. Guided by its core values of quality, respect, and integrity, by its track record of over forty years of commercial execution, and by its commitment to extending and improving the lives of cancer patients globally, Helsinn is the partner of choice for the biotech and pharma sector. With its leading position in cancer supportive care and strong focus in oncology and rare diseases, Helsinn is able to reach patients worldwide through its integrated CMC/manufacturing/supply and commercial platform complemented by scientific and technological expertise.

Helsinn has a commercial presence in 190 countries either directly, with its operating subsidiaries in the U.S. and China, or via its network of over forty long-standing trusted partners who share the same vision and values. The fully integrated supply chain and product development provided through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd., which cater to specific customer needs, are among the key services Helsinn offers its partners.

The Helsinn Group plays an active and central role in promoting social transformation in favor of people and the environment. Sustainability is at the heart of everything it does, which is reinforced in the company’s strategic plan by a commitment to sustainable growth.

To learn more about Helsinn please visit and follow us on Twitter and LinkedIn